Lung cancer risk score for ever and never smokers in China

被引:7
|
作者
Ma, Zhimin [1 ,2 ,3 ]
Lv, Jun [4 ,5 ]
Zhu, Meng [1 ,2 ]
Yu, Canqing [4 ]
Ma, Hongxia [1 ,2 ]
Jin, Guangfu [1 ,2 ]
Guo, Yu [6 ]
Bian, Zheng [6 ]
Yang, Ling [7 ,8 ]
Chen, Yiping [7 ,8 ]
Chen, Zhengming [7 ,8 ]
Hu, Zhibin [1 ,2 ]
Li, Liming [7 ,8 ,11 ]
Shen, Hongbing [1 ,2 ,9 ,10 ]
机构
[1] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatmen, Nanjing, Jiangsu, Peoples R China
[3] Southeast Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing, Jiangsu, Peoples R China
[4] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China
[5] Peking Univ, Key Lab Mol Cardiovasc Sci, Minist Educ, Beijing, Peoples R China
[6] Chinese Acad Med Sci, Beijing, Peoples R China
[7] Univ Oxford, Clin Trial Serv Unit, Oxford, Oxfordshire, England
[8] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, Oxfordshire, England
[9] Chinese Acad Med Sci, Res Units Cohort Study Cardiovasc Dis & Canc, Beijing, Peoples R China
[10] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Dept Epidemiol, Nanjing 211166, Jiangsu, Peoples R China
[11] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China
基金
中国国家自然科学基金;
关键词
early-onset cancer; lung cancer screening; lung cancer; never smokers; prediction model; DOSE-RESPONSE RELATIONSHIP; THAN; 50; YEARS; PREDICTION MODEL; CIGARETTE-SMOKING; VALIDATION; SELECTION; BIOBANK; MARKERS;
D O I
10.1002/cac2.12463
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMost lung cancer risk prediction models were developed in European and North-American cohorts of smokers aged & GE; 55 years, while less is known about risk profiles in Asia, especially for never smokers or individuals aged < 50 years. Hence, we aimed to develop and validate a lung cancer risk estimate tool for ever and never smokers across a wide age range. MethodsBased on the China Kadoorie Biobank cohort, we first systematically selected the predictors and explored the nonlinear association of predictors with lung cancer risk using restricted cubic splines. Then, we separately developed risk prediction models to construct a lung cancer risk score (LCRS) in 159,715 ever smokers and 336,526 never smokers. The LCRS was further validated in an independent cohort over a median follow-up of 13.6 years, consisting of 14,153 never smokers and 5,890 ever smokers. ResultsA total of 13 and 9 routinely available predictors were identified for ever and never smokers, respectively. Of these predictors, cigarettes per day and quit years showed nonlinear associations with lung cancer risk (Pnon-linear < 0.001). The curve of lung cancer incidence increased rapidly above 20 cigarettes per day and then was relatively flat until approximately 30 cigarettes per day. We also observed that lung cancer risk declined sharply within the first 5 years of quitting, and then continued to decrease but at a slower rate in the subsequent years. The 6-year area under the receiver operating curve for the ever and never smokers' models were respectively 0.778 and 0.733 in the derivation cohort, and 0.774 and 0.759 in the validation cohort. In the validation cohort, the 10-year cumulative incidence of lung cancer was 0.39% and 2.57% for ever smokers with low (< 166.2) and intermediate-high LCRS (& GE; 166.2), respectively. Never smokers with a high LCRS (& GE; 21.2) had a higher 10-year cumulative incidence rate than those with a low LCRS (< 21.2; 1.05% vs. 0.22%). An online risk evaluation tool (LCKEY; ) was developed to facilitate the use of LCRS. ConclusionsThe LCRS can be an effective risk assessment tool designed for ever and never smokers aged 30 to 80 years.
引用
收藏
页码:877 / 895
页数:19
相关论文
共 50 条
  • [41] Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers
    Jyoti Malhotra
    Tim Waterboer
    Michael Pawlita
    Angelika Michel
    Qiuyin Cai
    Wei Zheng
    Yu-Tang Gao
    Qing Lan
    Nathaniel Rothman
    Hilde Langseth
    Tom K Grimsrud
    Jian-Min Yuan
    Woon-Puay Koh
    Renwei Wang
    Alan A Arslan
    Anne Zeleniuch-Jacquotte
    Paolo Boffetta
    British Journal of Cancer, 2016, 115 : 1131 - 1139
  • [42] Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?
    ten Haaf, Kevin
    de Koning, Harry J.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : 1285 - 1291
  • [43] Lung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors
    Samet, Jonathan M.
    Avila-Tang, Erika
    Boffetta, Paolo
    Hannan, Lindsay M.
    Olivo-Marston, Susan
    Thun, Michael J.
    Rudin, Charles M.
    CLINICAL CANCER RESEARCH, 2009, 15 (18) : 5626 - 5645
  • [44] Environmental polycyclic aromatic hydrocarbons and risk of lung cancer in never smokers
    Mesaros, Clementina
    Penning, Trevor
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [45] Analysis of Lung Cancer Risk in Never Smokers with a Family History of Lung Cancer: A Cohort Study
    Lee, Y. -G.
    Seo, D.
    Kang, D. -Y.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S433 - S433
  • [46] Polygenic risk score and lung adenocarcinoma risk among never-smokers by EGFR mutation status
    Blechter, Batel
    Hsiung, Chao Agnes
    Matsuo, Keitaro
    Shiraishi, Kouya
    Wang, Kevin
    Zhang, Haoyu
    Seow, Wei Jie
    Shi, Jianxin
    Chatterjee, Nilanjan
    Wong, Jason Y. Y.
    Dai, Juncheng
    Hosgood, H. Dean
    Chang, I-Shou
    Choi, Jiyeon
    Hu, Wei
    Zheng, Wei
    Kim, Young Tae
    Shu, Xiao-Ou
    Cai, Qiuyin
    Yang, Pan-Chyr
    Lin, Dongxin
    Chen, Kexin
    Wu, Yi-Long
    Shen, Hongbin
    Kohno, Takashi
    Chanock, Stephen J.
    Rothman, Nathaniel
    Lan, Qing
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Lung cancer and obstructive lung disease in never smokers
    Yoneyama, Remi
    Saji, Hisashi
    Takeuchi, Susumu
    Ikeda, Norihiko
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 3934 - 3939
  • [48] The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer
    Muallaoglu, Sadik
    Karadeniz, Cemile
    Mertsoylu, Huseyin
    Besen, Ali Ayberk
    Sezer, Ahmet
    Sedef, Ali Murat
    Kose, Fatih
    Ozyilkan, Ozgur
    JOURNAL OF BUON, 2014, 19 (02): : 453 - 458
  • [49] Non-small cell lung cancer in never- and ever-smokers: Is it the same disease?
    Tang, Andrew
    Ahmad, Usman
    Toth, Andrew J.
    Bourdakos, Natalie
    Raja, Siva
    Raymond, Daniel P.
    Blackstone, Eugene H.
    Murthy, Sudish C.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 161 (06): : 1903 - +
  • [50] Polymorphisms in the H19 gene and the risk of lung Cancer among female never smokers in Shenyang, China
    Zhihua Yin
    Zhigang Cui
    Hang Li
    Juan Li
    Baosen Zhou
    BMC Cancer, 18